Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze GWW stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate GWW investment potential.

What is GWW stock price today?

Get real-time GWW stock price, historical data, and price charts on Financhill. Track GWW performance with our advanced analysis tools.

Is GWW a good investment?

Evaluate GWW investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy GWW stock?

To buy GWW stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of GWW?

View detailed market capitalization data and company valuation metrics for GWW on our comprehensive analysis page.

What is the P/E ratio of GWW?

Use our fundamental analysis tools to view GWW P/E ratio and compare valuation metrics with industry peers.

What are GWW earnings?

View GWW earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

W.W. Grainger, Inc. 10K Form

Buy

GWW
W.W. Grainger, Inc.

Last Price:

$1,125.48

Seasonality Move:

3.07%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2026-02-15	10K	GWW/W.W. Grainger, Inc. Annual
2026-01-15	10K	GWW/W.W. Grainger, Inc. Annual
2025-12-15	10K	GWW/W.W. Grainger, Inc. Annual

Receive GWW News And Ratings

See the #1 stock for the next 7 days that we like better than GWW

GWW Financial Statistics

Sales & Book Value

Annual Sales:	$17.9B
Cash Flow:	$269M
Price / Cash Flow:	40.62
Annual Sales:	$78.79
Price / Book:	14.34

Profitability

EPS (TTM):	35.55060
Net Income (TTM):	$1.8B
Gross Margin:	$6.9B
Return on Equity:	45.81%
Return on Assets:	20.44%

W.W. Grainger, Inc. Earnings Forecast

Key W.W. Grainger, Inc. Financial Ratios

The Gross Profit Margin over the past 46 years for GWW is 38.61%.
The Selling, General & Administrative Expenses for GWW have been equal to 25.16% of Gross Profit Margin.
The Research & Development expenses have been 0.00% of Revenue.
The Interest Expense is 4.48% of Operating Income.
The Net Earning history of GWW is 10.08% of Total Revenues.
Per Share Earnings over the last 46 years have been positive in 32 years.

W.W. Grainger, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	S&P500
Industry:	Trading Companies & Distributors
Sector:	Industrials
Current Symbol:	GWW
CUSIP:	384802
Website:	grainger.com

Debt

Debt-to-Equity Ratio:	0.77
Current Ratio:	2.83
Quick Ratio:	1.52

Price-to-Earnings

Trailing P/E Ratio:	31.71
Forward P/E Ratio:	23.35

GWW Technical Analysis vs Fundamental Analysis

Buy

W.W. Grainger, Inc. (GWW) is a Buy

Is W.W. Grainger, Inc. a Buy or a Sell?

W.W. Grainger, Inc. stock is rated a Buy

The current W.W. Grainger, Inc. [GWW] share price is $1,127.07. The Score for GWW is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.